Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGM - Nasdaq Real Time Price USD

Arcturus Therapeutics Holdings Inc. (ARCT)

12.65
+0.48
+(3.94%)
At close: April 23 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
138,389
138,389
157,748
205,755
12,359
Operating Expense
234,058
234,058
235,953
193,578
215,211
Operating Income
-95,669
-95,669
-78,205
12,177
-202,852
Net Non Operating Interest Income Expense
15,195
15,195
16,591
-420
-1,921
Other Income Expense
-471
-471
33,724
-1,113
1,099
Pretax Income
-80,945
-80,945
-27,890
10,644
-203,674
Tax Provision
-4
-4
1,835
1,295
--
Net Income Common Stockholders
-80,941
-80,941
-29,725
9,349
-203,674
Diluted NI Available to Com Stockholders
-80,941
-80,941
-29,725
9,349
-203,674
Basic EPS
-3.00
--
-1.00
0.35
-7.74
Diluted EPS
-3.00
--
-1.00
0.35
-7.74
Basic Average Shares
27,000
--
26,628
26,445
26,317
Diluted Average Shares
27,000
--
26,628
27,093
26,317
Total Operating Income as Reported
-95,669
-95,669
-78,205
12,177
-202,852
Total Expenses
234,058
234,058
235,953
193,578
215,211
Net Income from Continuing & Discontinued Operation
-80,941
-80,941
-29,725
9,349
-203,674
Normalized Income
-80,470.02
-80,470.02
-56,366.96
9,874.04
-204,258
Interest Income
15,195
15,195
17,359
2,581
753
Interest Expense
--
--
768
3,001
2,674
Net Interest Income
15,195
15,195
16,591
-420
-1,921
EBIT
-80,945
-80,945
-27,122
12,177
-202,852
EBITDA
-77,401
-77,401
-24,165
13,704
-201,659
Reconciled Depreciation
3,544
3,544
2,957
1,527
1,193
Net Income from Continuing Operation Net Minority Interest
-80,941
-80,941
-29,725
9,349
-203,674
Total Unusual Items Excluding Goodwill
-471
-471
33,724
-598
584
Total Unusual Items
-471
-471
33,724
-598
584
Normalized EBITDA
-76,930
-76,930
-57,889
14,302
-202,243
Tax Rate for Calcs
0
0
0
0
--
Tax Effect of Unusual Items
-0.02
-0.02
7,082.04
-72.96
--
12/31/2021 - 5/22/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EDIT Editas Medicine, Inc.
1.5600
0.00%
 
PHAT Phathom Pharmaceuticals, Inc.
4.0200
+1.52%
 
VIR Vir Biotechnology, Inc.
5.97
+2.93%
 
IMVT Immunovant, Inc.
14.45
+1.40%
 
NTLA Intellia Therapeutics, Inc.
8.09
-2.65%
 
DNLI Denali Therapeutics Inc.
14.87
+1.85%
 
RARE Ultragenyx Pharmaceutical Inc.
37.31
+3.90%
 
CAPR Capricor Therapeutics, Inc.
13.15
-5.33%
 
CVAC CureVac N.V.
3.1700
-0.63%
 
OCUL Ocular Therapeutix, Inc.
7.85
-0.76%